TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 110 filers reported holding TG THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,120,495 | -31.0% | 373,265 | +105.0% | 0.00% | 0.0% |
| Q2 2023 | $4,523,166 | +12.7% | 182,092 | -31.8% | 0.00% | 0.0% |
| Q1 2023 | $4,013,875 | -25.6% | 266,880 | -41.4% | 0.00% | -50.0% |
| Q4 2022 | $5,391,723 | +4015.8% | 455,767 | +1973.1% | 0.00% | – |
| Q3 2022 | $131,000 | -77.3% | 21,985 | -83.8% | 0.00% | – |
| Q2 2022 | $576,000 | -60.7% | 135,351 | -12.1% | 0.00% | – |
| Q1 2022 | $1,464,000 | -69.6% | 153,923 | -39.4% | 0.00% | -100.0% |
| Q4 2021 | $4,822,000 | +78.3% | 253,792 | +212.2% | 0.00% | 0.0% |
| Q3 2021 | $2,705,000 | +1008.6% | 81,291 | +1190.9% | 0.00% | – |
| Q2 2021 | $244,000 | -89.4% | 6,297 | -86.8% | 0.00% | -100.0% |
| Q1 2021 | $2,295,000 | +453.0% | 47,600 | +497.2% | 0.00% | – |
| Q4 2020 | $415,000 | +81.2% | 7,970 | -6.8% | 0.00% | – |
| Q3 2020 | $229,000 | +83.2% | 8,549 | +33.0% | 0.00% | – |
| Q2 2020 | $125,000 | -81.3% | 6,427 | -90.5% | 0.00% | – |
| Q1 2020 | $668,000 | +69.5% | 67,883 | +91.2% | 0.00% | – |
| Q4 2019 | $394,000 | -74.5% | 35,500 | -87.1% | 0.00% | -100.0% |
| Q3 2019 | $1,545,000 | -17.2% | 275,199 | +27.6% | 0.00% | 0.0% |
| Q2 2019 | $1,865,000 | +818.7% | 215,593 | +756.0% | 0.00% | – |
| Q1 2019 | $203,000 | -86.4% | 25,186 | -93.1% | 0.00% | -100.0% |
| Q4 2018 | $1,494,000 | +561.1% | 364,383 | +799.8% | 0.00% | – |
| Q3 2018 | $226,000 | -53.5% | 40,496 | +9.6% | 0.00% | – |
| Q2 2018 | $486,000 | -83.2% | 36,937 | -81.9% | 0.00% | -100.0% |
| Q1 2018 | $2,895,000 | +370.0% | 203,860 | +171.5% | 0.00% | – |
| Q4 2017 | $616,000 | -55.0% | 75,094 | -35.0% | 0.00% | -100.0% |
| Q3 2017 | $1,368,000 | +635.5% | 115,459 | +524.1% | 0.00% | – |
| Q2 2017 | $186,000 | +8.8% | 18,499 | +26.7% | 0.00% | – |
| Q1 2017 | $171,000 | +242.0% | 14,606 | +34.4% | 0.00% | – |
| Q4 2016 | $50,000 | -7.4% | 10,870 | +55.4% | 0.00% | – |
| Q3 2016 | $54,000 | +12.5% | 6,997 | -10.2% | 0.00% | – |
| Q2 2016 | $48,000 | -52.5% | 7,790 | -34.6% | 0.00% | – |
| Q1 2016 | $101,000 | -88.7% | 11,904 | -84.2% | 0.00% | -100.0% |
| Q4 2015 | $897,000 | +392.9% | 75,184 | +316.0% | 0.00% | – |
| Q3 2015 | $182,000 | +65.5% | 18,071 | +173.8% | 0.00% | – |
| Q2 2015 | $110,000 | 0.0% | 6,600 | -7.0% | 0.00% | – |
| Q1 2015 | $110,000 | -19.7% | 7,100 | -17.3% | 0.00% | – |
| Q4 2014 | $137,000 | – | 8,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |